Metraipolis › archive › dc_4b013de715ca

Targeting Inflammation by Pioglitazone and its R-Enantiomer Mitigates Pathological Myocardial Remodeling in Murine Hypertrophic Cardiomyopathy — Europe PMC PMID:42287760

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42287760
DOI
10.1016/j.jacbts.2026.101574
License (as archived)
solo-consultazione
Archived
2026-10-08T05:23:55.160Z
SHA-256 of the archived text
6b7076d901610961382519a9455545e2b75d23da30840dc3f76608f096589e14
Stable URL of this page
https://metraipolis.com/documento/dc_4b013de715ca

How to cite

Targeting Inflammation by Pioglitazone and its R-Enantiomer Mitigates Pathological Myocardial Remodeling in Murine Hypertrophic Cardiomyopathy — Europe PMC PMID:42287760 — Europe PMC (en), https://europepmc.org/article/MED/42287760 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4b013de715ca (Metraipolis archive dc_4b013de715ca, sha256 6b7076d901610961382519a9455545e2b75d23da30840dc3f76608f096589e14)
BibTeX
@misc{dc4b013de715ca,
  title = {Targeting Inflammation by Pioglitazone and its R-Enantiomer Mitigates Pathological Myocardial Remodeling in Murine Hypertrophic Cardiomyopathy — Europe PMC PMID:42287760},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42287760},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4b013de715ca; sha256 6b7076d901610961382519a9455545e2b75d23da30840dc3f76608f096589e14},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42287760. Agents can read the archived copy with the MCP tool read_document.